Introduction
In 2022, a significant study titled "Common and rare variant associations with clonal haematopoiesis phenotypes" was published in Nature, exploring the genetic underpinnings of clonal haematopoiesis (CH). CH is a condition characterized by the disproportionate contribution of a single hematopoietic stem cell to blood cell production, a phenomenon linked to increased risks of hematologic malignancies and cardiovascular disease. Recently, an official Author Correction was issued to clarify the protocols for accessing the foundational data used in this research.
The Nature of the Correction
The primary purpose of this correction is to update the "Data availability" section of the original publication. In large-scale genomic studies, providing clear and actionable pathways for data access is vital for the principles of open science, allowing for peer verification and the advancement of follow-up research.
The correction ensures that both the HTML and PDF versions of the original article accurately describe the specific mechanisms through which the scientific community can request individual-level genomic data. This update does not alter the scientific findings, statistics, or conclusions of the original study.
Data Availability and Access Protocols
The research utilized extensive individual-level genomic data from the Geisinger Health System (GHS). The updated statement clarifies the following regarding data access:
- Access Portal: Qualified academic researchers can request access through the Regeneron pre-clinical Research portal.
- Eligibility: Access is restricted to non-commercial academic researchers.
- Requirements: Researchers must enter into a formal data access agreement to ensure the ethical and secure handling of sensitive genomic information.
Significance for the Research Community
This administrative update underscores the importance of data stewardship and the collaborative role of industry partners, such as the Regeneron Genetics Center, in managing and distributing large-scale datasets. By providing a functional and transparent pipeline for data requests, the authors maintain the integrity of the original findings and support ongoing investigations into the genetic drivers of clonal haematopoiesis. Clear data availability statements are essential for the reproducibility of high-impact genomic research.
Summary updated